USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$853.66M
Market Cap
-
P/E Ratio
-0.42
EPS
$8.77
52 Week High
$2.36
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$147K |
Total Revenue | $0 |
Cost Of Revenue | $147K |
Costof Goods And Services Sold | $147K |
Operating Income | -$52M |
Selling General And Administrative | $12M |
Research And Development | $39M |
Operating Expenses | $52M |
Investment Income Net | - |
Net Interest Income | $3.6M |
Interest Income | $3.6M |
Interest Expense | $4K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $147K |
Income Before Tax | -$48M |
Income Tax Expense | -$30K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$48M |
Comprehensive Income Net Of Tax | - |
Ebit | -$48M |
Ebitda | -$48M |
Net Income | -$48M |
Field | Value (USD) |
---|---|
Total Assets | $111M |
Total Current Assets | $109M |
Cash And Cash Equivalents At Carrying Value | $34M |
Cash And Short Term Investments | $34M |
Inventory | - |
Current Net Receivables | $532K |
Total Non Current Assets | $1.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $74M |
Other Current Assets | $1.3M |
Other Non Current Assets | - |
Total Liabilities | $11M |
Total Current Liabilities | $11M |
Current Accounts Payable | $3.4M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $570K |
Total Non Current Liabilities | $747K |
Capital Lease Obligations | $1M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1M |
Other Current Liabilities | $6.5M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $100M |
Treasury Stock | - |
Retained Earnings | -$287M |
Common Stock | $94K |
Common Stock Shares Outstanding | $101M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$38M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $147K |
Capital Expenditures | $35K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$22M |
Cashflow From Financing | $61M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$48M |
Field | Value (USD) |
---|---|
Gross Profit | -$147K |
Total Revenue | $0 |
Cost Of Revenue | $147K |
Costof Goods And Services Sold | $147K |
Operating Income | -$52M |
Selling General And Administrative | $12M |
Research And Development | $39M |
Operating Expenses | $52M |
Investment Income Net | - |
Net Interest Income | $3.6M |
Interest Income | $3.6M |
Interest Expense | $4K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $147K |
Income Before Tax | -$48M |
Income Tax Expense | -$30K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$48M |
Comprehensive Income Net Of Tax | - |
Ebit | -$48M |
Ebitda | -$48M |
Net Income | -$48M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious neurology-mediated conditions. The company is headquartered in New Haven, Connecticut.